PDF Standards CLSI QMS11-Ed2 (R2019)
Management of Nonconforming Laboratory Events, QMS11Ed2E
standard by Clinical and Laboratory Standards Institute, 08/25/2015
Management of Nonconforming Laboratory Events, QMS11Ed2E
standard by Clinical and Laboratory Standards Institute, 08/25/2015
Performance Standards for Antimicrobial Susceptibility Testing, 31st Edition, M100Ed31E, Includes Correction (2021)
standard by Clinical and Laboratory Standards Institute, 03/23/2021
Accuracy in Patient and Sample Identification; Approved Guideline, GP33A
standard by Clinical and Laboratory Standards Institute, 03/01/2010
Apolipoprotein Immunoassays: Development and Recommended Performance Characteristics; Approved Guideline, C59AE
standard by Clinical and Laboratory Standards Institute, 09/19/1997
Protocol for the Evaluation, Validation, and Implementation of Coagulometers; Approved Guideline, H57-A
standard by Clinical and Laboratory Standards Institute, 01/01/2008
Development of In Vitro Susceptibility Testing Criteria and Quality Control Parameters, 5th Edition, M23Ed5E
standard by Clinical and Laboratory Standards Institute, 01/16/2018
Quality Management System: Leadership and Management Roles and Responsibilities; Approved Guideling, QMS14AE
standard by Clinical and Laboratory Standards Institute, 12/01/2012
Clinical Evaluation of Immunoassays; Approved Guideline–Second Edition, ILA21A2E
standard by Clinical and Laboratory Standards Institute, 01/01/2008
Laboratory Quality Control Based on Risk Management; Approved Guideline, EP23AE
standard by Clinical and Laboratory Standards Institute, 10/01/2011
Principles and Procedures for the Development of Epidemiological Cutoff Values for Antifungal Susceptibility Testing
standard by Clinical and Laboratory Standards Institute, 04/25/2016